Skip to main content
. Author manuscript; available in PMC: 2012 Jul 30.
Published in final edited form as: Stat Med. 2011 Feb 23;30(17):2070–2080. doi: 10.1002/sim.4069

Figure 1.

Figure 1

From left to right: pseudodata POM 1 is utilized in Scenarios A and C and has a starting dose of 1060 mg for a 30% DLT rate, and pseudodata POM 2 is utilized in Scenarios B and D and has a starting dose equal to 2145 mg for a 30% DLT rate